tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Low, 18 are a HOLD (43.9%), 21 are a BUY (51.22%), 2 are a SELL (4.88%).
Analyst David Low, currently employed at JPMORGAN, carries an average stock price target met ratio of 73.81% that have a potential upside of 33.16% achieved within 238 days. Previously, David Low worked at OPPENHEIMER, MORGAN STANLEY.
David Low’s has documented 68 price targets and ratings displayed on 4 stocks. The coverage is on Healthcare, Consumer Cyclical, Industrials sectors.
Most recent stock forecast was given on RMD, ResMed at 15-Apr-2026.
Analyst best performing recommendations are on NN (NEXTNAV ACQUISITION CORP).
The best stock recommendation documented was for RMD (RESMED) at 5/21/2021. The price target of $219 was fulfilled within 24 days with a profit of $26.12 (13.54%) receiving and performance score of 5.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Aug-2026
$262
$43.11 (19.69%)
$244
20 days ago
(15-Sep-2026)
25/32 (78.13%)
$32.56 (14.19%)
298
Buy Since 06-Feb-2024
$267
$48.11 (21.98%)
$255
1 months 4 days ago
(31-Aug-2026)
6/12 (50%)
$26.9 (11.20%)
152
Hold Since 19-Aug-2026
$230
$8 (3.60%)
1 months 16 days ago
(19-Aug-2026)
1/1 (100%)
$0.01 (0.00%)
2
Hold Since 13-Oct-2025
$215
$-3.89 (-1.78%)
$225
1 months 28 days ago
(07-Aug-2026)
4/5 (80%)
$3.67 (1.74%)
40
Hold Since 10-Jan-2025
$225
$6.11 (2.79%)
$275
1 months 28 days ago
(07-Aug-2026)
5/6 (83.33%)
$13.67 (6.47%)
51
Which stock is David Low most bullish on?
What Year was the first public recommendation made by David Low?
